At OPM, optimization isn't just something we do. It's the principle behind everything we build. By combining high-performance cell culture media with end-to-end biologics CRDMO services, we help biopharma teams move programs forward faster, improve manufacturing outcomes, and bring life-saving therapies to patients sooner.
Most service providers focus on either media development or manufacturing. OPM integrates both.
By combining advanced cell culture media expertise with biologics CRDMO capabilities, we can identify optimization opportunities earlier, reduce technology transfer risks, and accelerate the path from development to commercial manufacturing.
